Codexis Inc (CDXS)
3.50
+0.10
(+2.94%)
USD |
NASDAQ |
May 21, 16:00
3.50
0.00 (0.00%)
After-Hours: 20:00
Codexis Accounts Payable (Quarterly): 3.465M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 3.465M |
December 31, 2023 | 5.947M |
September 30, 2023 | 3.098M |
June 30, 2023 | 4.042M |
March 31, 2023 | 4.494M |
December 31, 2022 | 3.246M |
September 30, 2022 | 2.621M |
June 30, 2022 | 2.015M |
March 31, 2022 | 1.949M |
December 31, 2021 | 2.995M |
September 30, 2021 | 3.281M |
June 30, 2021 | 3.164M |
March 31, 2021 | 3.569M |
December 31, 2020 | 2.97M |
September 30, 2020 | 2.499M |
June 30, 2020 | 2.637M |
March 31, 2020 | 2.441M |
December 31, 2019 | 2.621M |
September 30, 2019 | 1.743M |
June 30, 2019 | 2.164M |
March 31, 2019 | 2.18M |
December 31, 2018 | 3.05M |
September 30, 2018 | 2.28M |
June 30, 2018 | 3.082M |
March 31, 2018 | 2.597M |
Date | Value |
---|---|
December 31, 2017 | 3.545M |
September 30, 2017 | 4.474M |
June 30, 2017 | 3.633M |
March 31, 2017 | 3.493M |
December 31, 2016 | 4.232M |
September 30, 2016 | 2.123M |
June 30, 2016 | 2.651M |
March 31, 2016 | 2.85M |
December 31, 2015 | 3.399M |
September 30, 2015 | 1.174M |
June 30, 2015 | 1.708M |
March 31, 2015 | 1.952M |
December 31, 2014 | 4.673M |
September 30, 2014 | 2.542M |
June 30, 2014 | 3.329M |
March 31, 2014 | 3.487M |
December 31, 2013 | 3.961M |
September 30, 2013 | 1.49M |
June 30, 2013 | 1.545M |
March 31, 2013 | 4.445M |
December 31, 2012 | 3.654M |
September 30, 2012 | 6.287M |
June 30, 2012 | 4.313M |
March 31, 2012 | 8.978M |
December 31, 2011 | 10.36M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.743M
Minimum
Sep 2019
5.947M
Maximum
Dec 2023
3.048M
Average
2.982M
Median
Accounts Payable (Quarterly) Benchmarks
Avidity Biosciences Inc | 2.349M |
Taysha Gene Therapies Inc | 10.38M |
Janux Therapeutics Inc | 2.254M |
Tango Therapeutics Inc | 3.898M |
2seventy bio Inc | 8.801M |